PLK1 and pancreatic adenocarcinoma: Overexpression of polo-like kinase 1 (PLK1), a crucial mitotic checkpoint protein for cell cycle progression, is associated with unfavorable prognoses in some cancers (e.g., pancreatic adenocarcinoma) [189].